Tag: potentially

ZURICH/NEW YORK, (Reuters) – Swiss drugmaker Novartis on Friday won U.S. approval for its gene therapy Zolgensma for spinal muscular atrophy (SMA), the leading genetic cause of death in infants, and priced the one-time treatment at a record $2.125 million. The Food and Drug Administration approved Zolgensma for children under the age of two with […]

Read more

<img title="Bayer hires law firm to probe Monsanto data collection " alt="Bayer hires law firm to probe Monsanto data collection " src="https://s4.reutersmedia.net/resources/r/?m=02&d=20190521&t=2&i=1389420955&r=LYNXNPEF4K0YZ&w=450" aria-label="FILE PHOTO: The so-called "Chempark", the main plant and headquarters of German Pharmaceutical and chemical maker Bayer AG is pictured along western Europe’s most important waterway in Leverkusen, Germany, May 14, 2019. REUTERS/Wolfgang […]

Read more

Patients who have had a stroke caused by bleeding in the brain can safely take aspirin to cut their risk of future strokes and heart problems, according to a new study. Aspirin thins the blood and so doctors have been cautious about giving it, fearing it could make bleeds worse. But The Lancet research suggests […]

Read more

WASHINGTON (Reuters) – China has pledged to stem a flood of the synthetic opioid fentanyl onto America’s streets, where it kills thousands of people a month, but U.S. security experts are skeptical about whether Beijing is willing, or even able, to follow through. FILE PHOTO: Packets of fentanyl mostly in powder form and methamphetamine, which […]

Read more

Oyster lovers, beware: Raw oysters harvested from Estero El Cardon in Baja California Sur, Mexico, have been linked to a gastrointestinal illness outbreak in California. Officials with the California Department of Public Health (CDPH) shared the news late last week, announcing between February and April at least 12 consumers who ate the oysters sold by […]

Read more

TORONTO (Reuters) – A tiny, little-known government agency is ramping up regulation of Canada’s Pharmaceutical industry, seeking to rein in prices for patented drugs that are among the highest in the world, according to industry sources and a Reuters analysis of government data. FILE PHOTO: A pharmacist counts pills in a pharmacy in Toronto, Ontario, […]

Read more

TOKYO/ZURICH (Reuters) – Novartis is buying dry-eye drug Xiidra from Takeda Pharmaceutical Co for up to $5.3 billion as the Swiss drugmaker refreshes its ophthalmic medicines portfolio with a potential blockbuster. FILE PHOTO: The logo of Swiss drugmaker Novartis AG is seen at its headquarters in Basel, Switzerland January 25, 2017. REUTERS/Arnd Wiegmann The deal, […]

Read more

(Reuters) – A Church of Scientology cruise ship quarantined by the Caribbean nation of St. Lucia for measles is due to arrive on Saturday back at its home port on the island of Curacao, where it will face similar restrictions, a top health official there said. A 440-foot ship owned and operated by the Church […]

Read more

(Reuters Health) – A tiny percentage of people at high risk for opioid overdose are getting prescriptions for naloxone, a medication that could potentially save their lives, a new study finds. Researchers determined that a mere 1.5 percent of high-risk patients were prescribed naloxone, which can reverse an overdose, according to the study published in […]

Read more

(Reuters Health) – One of the hardest things about being a new parent is figuring out when babies are so sick they need to go to the emergency room and when worrisome signs or symptoms might actually be perfectly normal, doctors say. Anxious parents bring babies to the ER for all kinds of things that […]

Read more